Molecular hydrogen (H2) as a potential treatment for acute and chronic fatigue

Many diseases as well as acute conditions can lead to fatigue, which can be either temporary or chronic in nature. Acute fatigue develops frequently after physical exercise or after alcohol hangover, whereas microbial infections such as influenza or COVID-19 and chronic diseases like Parkinson's disease or multiple sclerosis are often associated with chronic fatigue. Oxidative stress and a resulting disturbance of mitochondrial function are likely to be common denominators for many forms of fatigue, and antioxidant treatments have been shown to be effective in alleviating the symptoms of fatigue. In this study, we review the role of reactive oxygen and nitrogen species in fatigue and the antioxidant effects of the intake of molecular hydrogen. We propose that molecular hydrogen is well suited for the treatment of temporary and chronic forms of oxidative stress-associated fatigue.

Automated summary

Oxidative stress and mitochondrial dysfunction are common factors in causing various forms of fatigue, and antioxidant treatments are effective in relieving fatigue symptoms. This study discusses the antioxidant effects of molecular hydrogen intake and suggests that molecular hydrogen is well suited for the treatment of oxidative stress-associated temporary and chronic fatigue.